Lepu Medical Technology (Beijing) Co., Ltd.
300003
Classifica tra le azioni
#4731
Established in 1999 and headquartered in Beijing, China, Lepu Medical... Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare services. The company's extensive medical device portfolio primarily focuses on cardiovascular health. This includes interventional cardiology products such as coronary stents, balloons, catheters, guide wires, and related PCI accessories. It also provides solutions for structural heart diseases, like occluders, vascular plugs, delivery systems, and mechanical heart valves. Lepu Medical offers cardiac rhythm management products, including pacemakers, equipment, leads, and electrophysiology systems, alongside products for off-pump coronary artery bypass grafting and peripheral interventional devices such as PTA balloons and guide wires. Beyond cardiovascular applications, their offerings extend to critical care products like vascular access devices, needle-free connectors, blood samplers, and pressure transducers. The company also provides digital subtraction angiography (DSA) systems (both floor and suspended types), in vitro diagnostic (IVD) equipment and biomarkers, hemodialysis catheters and hollow fiber dialyzers, and general surgery instruments including surgical staplers and endo surgery accessories. In the pharmaceutical sector, Lepu Medical manufactures and distributes medications for various conditions. This encompasses a comprehensive range of cardiovascular drugs designed to treat issues like thrombosis, hyperlipidemia, hypertension, angina, and heart failure. Additionally, they produce beta-lactamase antibiotics and antifungal antimicrobial drugs, central nervous system medications (such as painkillers and antidepressants), treatments for gastric/duodenal ulcers and chronic liver disease, respiratory system drugs, hypoproteinemia drugs, and agents that activate blood circulation. Furthermore, Lepu Medical provides a diverse array of healthcare services. These include precision medicine, remote ECG telemonitoring, and specialized consulting and management centers for cardiovascular diseases. The company is also involved in medical science and technology incubation, equity investment, and offers medical financial services. Its service offerings extend to general health consultation, online pharmacy platforms, sales of household medical equipment, smart medical devices, and the operation of specialized hospitals focusing on cardiovascular care. Lepu Medical actively participates in the establishment and co-construction of cardiac catheterization laboratories (Cath Labs).
Prezzo delle azioni
$1.73
Capitalizzazione di mercato
$3.18B
Variazione (1 giorno)
2.76%
Variazione (1 anno)
-32.27%
Paese
CN
Scambia Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Categoria
Healthcare
Utile per Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Utile nel Jun 2026 TTM: $126.35M
Secondo gli ultimi rapporti finanziari di Lepu Medical Technology (Beijing) Co., Ltd., gli utili attuali della società sono $126.35M. Nel 2023, la società ha registrato un utile di $219.61M, una diminuzione rispetto a agli utili del 2022, che erano di $378.63M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Lepu Medical Technology (Beijing) Co., Ltd. dal 2006 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $126.35M | 308.51% |
| 2024 | $30.93M | -85.92% |
| 2023 | $219.61M | -42.00% |
| 2022 | $378.63M | 12.13% |
| 2021 | $337.66M | 0.12% |
| 2020 | $337.27M | 13.83% |
| 2019 | $296.30M | 38.28% |
| 2018 | $214.27M | 16.62% |
| 2017 | $183.74M | 43.18% |
| 2016 | $128.33M | 18.89% |
| 2015 | $107.94M | 24.59% |
| 2014 | $86.64M | 21.66% |
| 2013 | $71.21M | -7.45% |
| 2012 | $76.95M | -10.67% |
| 2011 | $86.13M | 20.29% |
| 2010 | $71.61M | 47.51% |
| 2009 | $48.54M | 64.22% |
| 2008 | $29.56M | 43.59% |
| 2007 | $20.59M | 102.13% |
| 2006 | $10.18M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $7.51B | 5,844.49% |
US
|
|
| $5.56B | 4,302.77% |
IE
|
|
| $5.15B | 3,974.32% |
US
|
|
| $3.86B | 2,955.74% |
US
|
|
| - | - |
DE
|
